From the Journals

Higher Heart Risk Seen in Inflammatory Arthritis With IFG

Prediabetes in inflammatory arthritis patients raised cardiovascular risk by over twofold, researchers reported in a population-based cohort study.

Share

A study of 13,905 patients with inflammatory arthritis revealed that those with impaired fasting glucose or using sulfonylureas may face a higher risk of major adverse cardiovascular events. Elevated glucose levels and certain diabetes medications were associated with increased cardiovascular risks, emphasizing the importance of proactive glucose management in patients with inflammatory arthritis.

Original Source(s)

Higher Heart Risk Seen in Inflammatory Arthritis With IFG

Prediabetes in inflammatory arthritis patients raised cardiovascular risk by over twofold, researchers reported in a population-based cohort study.

  • by Stanley Gajete

  • April 28, 2025

  • 3 min

Related Content

Sleep Disorders Linked to Higher RA Prevalence

Results suggest sleep-related inflammation may play a role in RA, though causality remains unclear.

What's Really Driving Arthritis Pain?

A narrative review suggests pain in rheumatoid arthritis and osteoarthritis extends beyond nociceptive mechanisms.

Evaluating IPFP Steroid Injections in OA

Randomized trial found no significant differences in pain or effusion synovitis compared with placebo, despite some favorable secondary findings.